Mineralys Therapeutics CMO Sells Shares
Meno di 1 minuto di lettura
| Reporter Name | Rodman David Malcom |
| Relationship | Chief Medical Officer |
| Type | Sell |
| Amount | $173,773 |
| SEC Filing | Form 4 |
Rodman David Malcom, Chief Medical Officer of Mineralys Therapeutics, sold 11,366 shares of common stock on May 14, 2025, at a weighted-average price of $15.2889 per share, totaling $173,773. Following the transaction, Malcom directly owns 106,669 shares of the company. The sale was conducted under a Rule 10b5-1 trading plan adopted on October 25, 2024.
SEC Filing: Mineralys Therapeutics, Inc. [ MLYS ] - Form 4 - May. 15, 2025